Published in Lab Business Week, August 29th, 2004
The financing is expected to occur in two closings, with the first closing resulting in aggregate gross proceeds to the company of approximately $17.9 million, scheduled to be completed early this week, subject to customary closing conditions.
A second and final closing resulting in additional gross proceeds of approximately $3.6 million should occur...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.